 |
|
|
|
UTE601
Fallopian tube disease spectrum (fallopian tube cancer progression) tissue array, 30 cases/60 cores
|
|
| Microarray Panel: | Oviductal cancer tissue microarray, containing 10 cases of each adenocarcinoma and inflammation, 1 hyperplasia, 4 adjacent normal tissue and 5 normal tissue, duplicate cores per case |
| Cores: | 60 |
|
| Cases: | 30 |
| Layout: | 10 cols × 6 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Actin confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Type † |
|
A1 |
1 |
F |
47 |
Fallopian tube |
Adenocarcinoma |
2 |
Malignant |
|
A2 |
2 |
F |
47 |
Fallopian tube |
Adenocarcinoma |
2 |
Malignant |
|
A3 |
3 |
F |
46 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
A4 |
4 |
F |
46 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
A5 |
5 |
F |
43 |
Fallopian tube |
Adenocarcinoma |
2–3 |
Malignant |
|
A6 |
6 |
F |
43 |
Fallopian tube |
Adenocarcinoma |
2–3 |
Malignant |
|
A7 |
7 |
F |
52 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
A8 |
8 |
F |
52 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
A9 |
9 |
F |
53 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
A10 |
10 |
F |
53 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
B1 |
11 |
F |
60 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
B2 |
12 |
F |
60 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
B3 |
13 |
F |
40 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
B4 |
14 |
F |
40 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
B5 |
15 |
F |
57 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
B6 |
16 |
F |
57 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
B7 |
17 |
F |
51 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
B8 |
18 |
F |
51 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
B9 |
19 |
F |
53 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
B10 |
20 |
F |
53 |
Fallopian tube |
Adenocarcinoma |
3 |
Malignant |
|
C1 |
21 |
F |
41 |
Fallopian tube |
Chronic inflammation (of smooth muscle) |
– |
Inflammation |
|
C2 |
22 |
F |
41 |
Fallopian tube |
Chronic inflammation (of smooth muscle) |
– |
Inflammation |
|
C3 |
23 |
F |
32 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
C4 |
24 |
F |
32 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
C5 |
25 |
F |
46 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
C6 |
26 |
F |
46 |
Fallopian tube |
Chronic inflammation (of fibrous tissue and smooth muscle) |
– |
Inflammation |
|
C7 |
27 |
F |
34 |
Fallopian tube |
Chronic inflammation (of fibrous tissue and smooth muscle) |
– |
Inflammation |
|
C8 |
28 |
F |
34 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
C9 |
29 |
F |
34 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
C10 |
30 |
F |
34 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
D1 |
31 |
F |
53 |
Fallopian tube |
Chronic inflammation (of fibrous tissue and smooth muscle) |
– |
Inflammation |
|
D2 |
32 |
F |
53 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
D3 |
33 |
F |
49 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
D4 |
34 |
F |
49 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
D5 |
35 |
F |
49 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
D6 |
36 |
F |
49 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
D7 |
37 |
F |
22 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
D8 |
38 |
F |
22 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
D9 |
39 |
F |
29 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
D10 |
40 |
F |
29 |
Fallopian tube |
Chronic inflammation |
– |
Inflammation |
|
E1 |
41 |
F |
27 |
Fallopian tube |
Chronic inflammation with hyperplasia of epithelium |
– |
Hyperplasia |
|
E2 |
42 |
F |
27 |
Fallopian tube |
Chronic inflammation with hyperplasia of epithelium |
– |
Hyperplasia |
|
E3 |
43 |
F |
56 |
Fallopian tube |
Cancer adjacent normal oviductal tissue |
– |
NAT |
|
E4 |
44 |
F |
56 |
Fallopian tube |
Cancer adjacent normal oviductal tissue |
– |
NAT |
|
E5 |
45 |
F |
34 |
Fallopian tube |
Cancer adjacent normal oviductal tissue |
– |
NAT |
|
E6 |
46 |
F |
34 |
Fallopian tube |
Cancer adjacent normal oviductal tissue |
– |
NAT |
|
E7 |
47 |
F |
26 |
Fallopian tube |
Cancer adjacent normal oviductal tissue (fibrous tissue and smooth muscle) |
– |
NAT |
|
E8 |
48 |
F |
26 |
Fallopian tube |
Cancer adjacent normal oviductal tissue |
– |
NAT |
|
E9 |
49 |
F |
47 |
Fallopian tube |
Cancer adjacent normal oviductal tissue |
– |
NAT |
|
E10 |
50 |
F |
47 |
Fallopian tube |
Cancer adjacent normal oviductal tissue |
– |
NAT |
|
F1 |
51 |
F |
21 |
Fallopian tube |
Normal oviductal tissue |
– |
Normal |
|
F2 |
52 |
F |
21 |
Fallopian tube |
Normal oviductal tissue |
– |
Normal |
|
F3 |
53 |
F |
15 |
Fallopian tube |
Normal oviductal tissue |
– |
Normal |
|
F4 |
54 |
F |
15 |
Fallopian tube |
Normal oviductal tissue |
– |
Normal |
|
F5 |
55 |
F |
18 |
Fallopian tube |
Normal oviductal tissue |
– |
Normal |
|
F6 |
56 |
F |
18 |
Fallopian tube |
Normal oviductal tissue |
– |
Normal |
|
F7 |
57 |
F |
21 |
Fallopian tube |
Normal oviductal tissue |
– |
Normal |
|
F8 |
58 |
F |
21 |
Fallopian tube |
Normal oviductal tissue |
– |
Normal |
|
F9 |
59 |
F |
21 |
Fallopian tube |
Normal oviductal tissue |
– |
Normal |
|
F10 |
60 |
F |
21 |
Fallopian tube |
Normal oviductal tissue |
– |
Normal |
|
–
|
– |
M |
58 |
Skin |
Malignant melanoma (tissue marker) |
– |
Malignant |
- No grading available. *Tissue dots may be missing or histologically unidentifiable
† For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
|
|
